Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.”  | The company benefited from higher-than-expected sales of ...

“The latitude that CDC and ... that a vaccine may be causing harm to some recipients. At its 2024 February meeting, the ACIP concluded that older adults who get the new RSV vaccines marketed ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

The worst flu season in years is swamping California, prompting a renewed surge in hospitalizations as officials warn the ...

Early signs of whooping cough in adults look very much like a common cold, Dr. Loafman says. For the first week or so of ...

Current data support the safety and effectiveness of RSV vaccines to prevent LRTD caused by the virus, and the CDC continues to ... preventative health recommendations,” Mazumder said.

This story has been corrected to include updated recommendations from the ... remains elevated across the country, the CDC said. Meanwhile, RSV activity is very high in many areas of the U.S ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is what you need to know.